iOncologi Acquires TargImmune to Boost Immunotherapy Pipeline
March 17, 2025
iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor